Wednesday, July 2, 2025

Psyched Wellness To Commence Trading Today

Psyched Wellness (CSE: PSYC) is the latest mushroom issue to hit the CSE, with the company set to begin trading today as per a bulletin filed by the exchange last night. The company is focused on health supplements, and is said to be “dedicated to the distribution of mushroom-derived products and associated consumer packaged goods.”

Presently, Psyched appears to be focused on the emerging functional food category, with a heavy focus on that of mushroom-derived products as a means of meeting its mission of providing products that promote stress relief and relaxation, assist with sleeping and supporting mood. The firm is said to currently be in the process of developing several products in the category, which included muscaria-derived teas, capsules and water-based extracts.

In terms of product development, it appears the company initiated research and development on the use of Amanita Muscaria as a functional mushroom supplement in the first quarter of 2020. From here, the company then completed an extraction protocol for the compound which will be used to commence pre-clinical trials on the extract as well as a product license application (PLA).

The company deck identifies that the function mushroom market is currently forecasted to hit US$34.3 billion by 2024, with a compound annual growth rate of 8.04%.

Perhaps one of the currently most notable aspects of Psyched Wellness is the leadership team behind it. Lead by CEO Jeff Stevens whom has over two decades of capital markets experience, Stevens has managed to assemble a notable board of directors, which contains current executives of Juul Labs Canada, as well as the former CEO and founder of Aurora Cannabis (TSX: ACB) (NYSE: ACB) Terry Booth.

In terms of share structure, Psyched Wellness presently has 104,642,930 common shares outstanding, with an additional 9,681,200 reserved for issuance. With the latest round of financing occurring at $0.10, the company is expected to hit the market with a capitalization of roughly $10.4 million.

Psyched Wellness is set to begin trading today under the symbol “PSYC” on the Canadian Securities Exchange.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

Psyched Wellness Launches Study On Mushroom Extract Focused On Gut Health

Psyched Wellness (CSE: PSYC) this morning issued a very brief press release related to ongoing...

Tuesday, March 30, 2021, 08:31:58 AM

Psyched Wellness: Canaccord Pens “Future In Fungi Report”

Yesterday morning, Canaccord Genuity released a primer into five psychedelic companies that they “believe could...

Tuesday, March 9, 2021, 11:49:00 AM

Psyched Wellness Announces Study On Muscimol Antioxidant and Anti-Inflammatory Properties

Psyched Wellness (CSE: PSYC) has begun yet another study related to that of the Amanita...

Wednesday, January 6, 2021, 07:48:08 AM

Psyched Wellness Completes 14 Day Oral Toxicity Preclinical Study For Proprietary Extract

Psyched Wellness (CSE: PSYC) this morning announced the results of its initial 14-day oral toxicity...

Tuesday, July 6, 2021, 08:58:10 AM

Psyched Wellness Begins Pre-Clinical Trials Of Amanita Muscaria Mushroom

Psyched Wellness (CSE: PSYC) this morning announced that it has commenced its pre-clinical trials of...

Wednesday, December 23, 2020, 08:02:43 AM